399 related articles for article (PubMed ID: 26320423)
21. Whole body simultaneous PET/MRI: one-stop-shop?
Maseeh-uz-Zaman ; Fatima N; Sajjad Z; Zaman U
J Pak Med Assoc; 2014 Feb; 64(2):201-4. PubMed ID: 24640813
[TBL] [Abstract][Full Text] [Related]
22. Positron emission tomography/magnetic resonance imaging (PET/MRI): An update and initial experience at HC-FMUSP.
Queiroz MA; Barbosa FG; Buchpiguel CA; Cerri GG
Rev Assoc Med Bras (1992); 2018 Jan; 64(1):71-84. PubMed ID: 29561945
[TBL] [Abstract][Full Text] [Related]
23. [Simultaneous whole-body PET-MRI in pediatric oncology : More than just reducing radiation?].
Gatidis S; Gückel B; la Fougère C; Schmitt J; Schäfer JF
Radiologe; 2016 Jul; 56(7):622-30. PubMed ID: 27306199
[TBL] [Abstract][Full Text] [Related]
24. [Clinical evaluation of female pelvic tumors : Application fields of integrated PET/MRI].
Grueneisen J; Umutlu L
Radiologe; 2016 Jul; 56(7):605-11. PubMed ID: 27315240
[TBL] [Abstract][Full Text] [Related]
25. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in hybrid molecular imaging systems.
Lee JS; Kim JH
Semin Musculoskelet Radiol; 2014 Apr; 18(2):103-22. PubMed ID: 24715444
[TBL] [Abstract][Full Text] [Related]
27. FDG PET and PET/CT.
Krause BJ; Schwarzenböck S; Souvatzoglou M
Recent Results Cancer Res; 2013; 187():351-69. PubMed ID: 23179888
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
29. [Why is PET/CT essential in urooncology?].
Borbély K; Géczi L; Kásler M
Magy Onkol; 2013 Dec; 57(4):282-96. PubMed ID: 24353995
[TBL] [Abstract][Full Text] [Related]
30. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
31. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
32. Combined PET/MRI: a new dimension in whole-body oncology imaging?
Antoch G; Bockisch A
Eur J Nucl Med Mol Imaging; 2009 Mar; 36 Suppl 1():S113-20. PubMed ID: 19104802
[TBL] [Abstract][Full Text] [Related]
33. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
34. Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/MRI for Lung Cancer Staging.
Ohno Y; Koyama H; Lee HY; Yoshikawa T; Sugimura K
J Thorac Imaging; 2016 Jul; 31(4):215-27. PubMed ID: 27075745
[TBL] [Abstract][Full Text] [Related]
35. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
36. Lymph node staging with dual-modality PET/CT: enhancing the diagnostic accuracy in oncology.
Veit P; Ruehm S; Kuehl H; Stergar H; Mueller S; Bockisch A; Antoch G
Eur J Radiol; 2006 Jun; 58(3):383-9. PubMed ID: 16476533
[TBL] [Abstract][Full Text] [Related]
37. Positron Emission Tomography/Magnetic Resonance Imaging of Gastrointestinal Cancers.
Goh V; Prezzi D; Mallia A; Bashir U; Stirling JJ; John J; Charles-Edwards G; MacKewn J; Cook G
Semin Ultrasound CT MR; 2016 Aug; 37(4):352-7. PubMed ID: 27342899
[TBL] [Abstract][Full Text] [Related]
38. [Whole-body tumor staging: MRI or FDG-PET/CT?].
Antoch G; Vogt FM; Bockisch A; Ruehm SG
Radiologe; 2004 Sep; 44(9):882-8. PubMed ID: 15349729
[TBL] [Abstract][Full Text] [Related]
39. PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.
Czernin J; Benz MR; Allen-Auerbach MS
Eur J Radiol; 2010 Mar; 73(3):470-80. PubMed ID: 20097498
[TBL] [Abstract][Full Text] [Related]
40. SPECT/CT, PET/CT and PET/MRI: oncologic and infectious applications and protocol considerations.
Voss SD
Pediatr Radiol; 2023 Jun; 53(7):1443-1453. PubMed ID: 36899268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
